APOC3 and metabolic dysfunction-associated steatotic liver disease: Compared to controls, patients with MASLD displayed significantly lower ApoC‐III proteoforms (ApoC‐III0, ApoC‐IIIi and ApoC‐IIIii; Figure 2A–C).